1. 029. PR3-ANCA STATUS FOLLOWING RITUXIMAB: A USEFUL BIOMARKER FOR RELAPSE PREDICTION IN ANCA-ASSOCIATED VASCULITIS. (29th March 2019) Authors: McClure, Mark; Wason, James; Gopaluni, Seerapani; Tieu, Joanna; Smith, Rona; Jayne, David; Jones, Rachel Journal: Rheumatology Issue: Volume 58(2019)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 322. A RANDOMISED, DOUBLE-BLIND, CONTROLLED, MECHANISTIC STUDY OF RITUXIMAB AND BELIMUMAB COMBINATION THERAPY IN PR3 ANCA-ASSOCIATED VASCULITIS (COMBIVAS): STUDY PROTOCOL. (29th March 2019) Authors: McClure, Mark; Gopaluni, Seerapani; Wason, James; Rosen, Antonella Napolitano; Henderson, Robert; Salama, Alan; Pusey, Charles; Jayne, David; Jones, Rachel Journal: Rheumatology Issue: Volume 58(2019)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A multi-stage drop-the-losers design for multi-arm clinical trials. (February 2017) Authors: Wason, James; Stallard, Nigel; Bowden, Jack; Jennison, Christopher Journal: Statistical methods in medical research Issue: Volume 26:Number 1(2017) Page Start: 508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A novel nano-iron supplement versus standard treatment for iron deficiency anaemia in children 6–35 months (IHAT-GUT trial): a double-blind, randomised, placebo-controlled non-inferiority phase II trial in The Gambia. (February 2023) Authors: Mohammed, Nuredin I.; Wason, James; Mendy, Thomas; Nass, Stefan A.; Ofordile, Ogochukwu; Camara, Famalang; Baldeh, Bakary; Sanyang, Chilel; Jallow, Amadou T.; Hossain, Ilias; Faria, Nuno; Powell, Jonathan J.; Prentice, Andrew M.; Pereira, Dora I.A. Journal: EClinicalMedicine Issue: Volume 56(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A two‐stage drop‐the‐losers design for time‐to‐event outcome using a historical control arm. (8th September 2021) Authors: Abbas, Rachid; Wason, James; Michiels, Stefan; Le Teuff, Gwénaël Journal: Pharmaceutical statistics Issue: Volume 21:Number 1(2022) Page Start: 268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. An adaptive design for updating the threshold value of a continuous biomarker. (14th July 2016) Authors: Spencer, Amy V.; Harbron, Chris; Mander, Adrian; Wason, James; Peers, Ian Journal: Statistics in medicine Issue: Volume 35:Number 27(2016) Page Start: 4909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Anti-VEGF intervention in neovascular AMD: benefits and risks restated as natural frequencies. Issue 1 (14th June 2019) Authors: Clearkin, Louis; Ramasamy, Balasubramanian; Wason, James; Tiew, Stephenie Journal: BMJ open ophthalmology Issue: Volume 4:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Capturing the real‐world benefit of residual β‐cell function during clinically important time‐periods in established Type 1 diabetes. Issue 5 (10th March 2022) Authors: Taylor, Guy S.; Shaw, Andy C.; Smith, Kieran; Wason, James; McDonald, Timothy J.; Oram, Richard A.; Stevenson, Emma; Shaw, James A. M.; West, Daniel J. Journal: Diabetic medicine Issue: Volume 39:Issue 5(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Comment on: Month of birth and risk of multiple sclerosis: confounding and adjustments. (10th April 2014) Authors: Fiddes, Barnaby; Wason, James; Sawcer, Stephen Journal: Annals of clinical and translational neurology Issue: Volume 1:Number 5(2014:May) Page Start: 375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Components of smartphone cognitive-behavioural therapy for subthreshold depression among 1093 university students: a factorial trial. Issue Volume 25:Issue e1(2022) (16th May 2022) Authors: Sakata, Masatsugu; Toyomoto, Rie; Yoshida, Kazufumi; Luo, Yan; Nakagami, Yukako; Uwatoko, Teruhisa; Shimamoto, Tomonari; Tajika, Aran; Suga, Hidemichi; Ito, Hiroshi; Sumi, Michihisa; Muto, Takashi; Ito, Masataka; Ichikawa, Hiroshi; Ikegawa, Masaya; Shiraishi, Nao; Watanabe, Takafumi; Sahker, Etha... Journal: Evidence-based mental health Issue: Volume 25:Issue e1(2022) Page Start: e18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗